Drug Delivery Device Market, By Route of Administration (Oral, Parenteral, Transdermal, Ocular, Pulmonary), By Application (Oncology, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders), By End User (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Feb 2025

Code : CMI5419

Pages :162

Formats :

Excel and PDF

Industry : Medical Devices

Drug Delivery Device Market Size and Trends

Global drug delivery device market is estimated to be valued at USD 229.14 Bn in 2025 and is expected to reach USD 419.14 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 9.0% from 2025 to 2032.

Drug Delivery Device Market Key Factors

To learn more about this report, Request sample copy

Growing prevalence of chronic diseases

Growing prevalence of chronic diseases across the globe has boosted demand for advanced drug delivery devices. Chronic diseases such as diabetes, cardiovascular diseases, respiratory diseases and others require long term medical treatment and management. These diseases are often associated with side effects of drugs used for treatment, which can be minimized through effective drug delivery methods. Advanced drug delivery devices offer a controlled and targeted delivery of drugs, which helps patients to manage chronic conditions efficiently.

Many developed nations have witnessed substantial rise in life expectancy and aging population is more prone to chronic health issues. Developing countries are also witnessing epidemiological transition where infectious diseases are declining and non-communicable chronic diseases are increasing. This can be attributed to changes in lifestyle and environmental factors. Growing patient pool of chronic diseases worldwide has created an enormous market for innovative drug delivery devices. Companies are investing heavily in R&D to develop devices providing sustained release, minimal drug degradation and improved patient compliance. Wearable and portable delivery devices are gaining popularity for their convenience in administering drugs effectively without major lifestyle alterations.

Rising cases of diabetes can also drive the market growth. As per WHO, over 460 million people suffered with diabetes. Advanced insulin pens, pumps and inhalable formulations are revolutionizing diabetes management. Respiratory diseases also contribute significantly with over 300 million people suffering from asthma. Inhalers and nebulizers offering controlled medication delivery directly to lungs witness huge demand. Biologics have emerged as mainstay treatment for various cancers, autoimmune disorders and other chronic therapies. However, biologics are fragile large molecules having limited shelf life when administered conventionally. Specialized devices enabling stable storage and injectable delivery of biologics are opening new opportunities.